变异二期回肠储袋肛管吻合术:溃疡性结肠炎的安全有效替代术式
本研究比较溃疡性结肠炎患者接受变异二期与经典二期IPAA的术后储袋漏发生情况。248例患者中,变异二期组3年储袋漏累积发生率与标准单期或二期手术无显著差异(风险差0.01;95%CI -0.08, 0.15),且变异二期组患者基线更急重(低BMI、紧急手术、近期生物制剂及高剂量激素使用比例更高)。
要点
- 变异二期IPAA先全腹结肠切除+末端回肠造口,再行完成性直肠切除+IPAA,不设转流性回肠造口
- 变异二期组3年储袋漏累积发生率与经典二期相当,风险差0.01(95%CI -0.08, 0.15)
- 接受变异二期手术者基线更急重:低BMI、紧急手术、近期生物制剂及高剂量激素比例更高
核心结论
- 变异二期IPAA是安全有效的手术方式,在更急重人群中结局与经典二期相当。
研究设计与样本
- 回顾性队列研究,纳入2003至2010年北卡罗来纳大学医院因溃疡性结肠炎行IPAA的248例患者。
- 139例(56.1%)行经典二期,109例(43.9%)行变异二期。
- 采用逆概率治疗加权Kaplan-Meier生存曲线比较3年储袋漏累积发生率,95%CI用非参数自举法估计。
主要发现
- 标准化后,变异二期与标准单期或二期手术的3年储袋漏累积发生率无显著差异(风险差0.01;95%CI -0.08, 0.15)。
- 首次手术时,变异二期组BMI更低(中位22.5 kg/m2 vs 26.7 kg/m2;p < 0.0001)。
- 变异二期组紧急/急诊手术比例更高(56.9% vs 0.0%;p < 0.0001)。
- 变异二期组术前2周内使用生物制剂比例更高(32.1% vs 17.5%;p = 0.003)。
- 变异二期组高剂量激素使用比例更高(60.4% vs 16.7%;p ≤ 0.0001)。
临床怎么用
- 对于因急性加重或激素/生物制剂暴露而需手术的溃疡性结肠炎患者,可考虑变异二期IPAA作为经典术式的替代。
- 变异二期IPAA不设转流性回肠造口,需权衡储袋漏风险与造口相关并发症。
局限性
- 单中心回顾性研究,样本来自2003至2010年,外推需谨慎。
- 变异二期组基线病情更急重,尽管采用逆概率加权,仍可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ulcerative colitis patients have been historically treated with standard single, 2-, and 3-stage operative approaches. We perform a variant 2-stage procedure beginning with total abdominal colectomy and end ileostomy followed by completion proctectomy and ileal pouch-anal anastomosis (IPAA) without a diverting loop ileostomy. This study evaluates the effectiveness of this innovative alternative. STUDY DESIGN: Patients with ulcerative colitis, admitted to the University of North Carolina Hospital between 2003 and 2010 for IPAA, were eligible for inclusion. The 3-year cumulative incidence of pouch leaks among patients undergoing variant 2-stage were compared with those undergoing classic 2-stage, using inverse probability-of-treatment weighted Kaplan- Meier survival curves, and 95% CIs were estimated using nonparametric bootstrapping. RESULTS: There were 248 patients who underwent IPAA; 139 (56.1%) underwent classic 2-stage and 109 (43.9%) underwent variant 2-stage. After standardization, there was no significant difference in the 3-year cumulative incidence of pouch leaks between patients undergoing variant 2-stage, compared with the standard single- or 2-stage procedure (risk difference 0.01; 95% CI -0.08, 0.15). At the time of the first surgical procedure, patients undergoing a variant 2-stage were more likely to have lower BMIs (median 22.5 kg/m2 vs 26.7 kg/m2; p < 0.0001), an urgent/emergent procedure (56.9% vs 0.0%; p < 0.0001), biologic use within 2 weeks of surgery (32.1% vs 17.5%; p = 0.003), and high dose steroid use (60.4% vs 16.7%; p ≤ 0.0001). CONCLUSIONS: Variant 2-stage IPAA is a safe and effective operative approach with comparable outcomes in a more acute population based on BMI, steroid use, and urgency of operation.
引用
- Samples J, Evans K, Chaumont N, et al. Variant Two-Stage Ileal Pouch-Anal Anastomosis: An Innovative and Effective Alternative to Standard Resection in Ulcerative Colitis. J Am Coll Surg. 2017. PMID: 28315811. doi:10.1016/j.jamcollsurg.2016.12.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。